Skip to main content

Table 1 Inclusion and exclusion criteria

From: Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study

Inclusion criteria

Exclusion criteria

• Age between 50 and 70 years

• Women surgically treated for left or right breast cancer and for whom adjuvant treatment is radiotherapy with irradiation of the breast or chest wall irradiation and possibly ganglion chains,

• Adjuvant radiotherapy with 3D CRT performed in Clinique Pasteur Toulouse

• WHO performance status ECOG (Eastern Cooperative Oncology Group - index usually used to describe the patient's condition) = 0 or 1

• Being volunteer to participate in the study and having signed the consent form

• Indication of adjuvant chemotherapy

• Clinically or radiologically detectable metastasis

• Personal history of coronary artery disease or myocardial disease

• Personal history of breast cancer or other cancer requiring radiotherapy to the thorax

• Patient with controlled infection or severe disease and/or non-hazardous to their participation in the study

• Contraindications to injection of iodinated contrast (for CCTA): pregnancy, renal failure, allergy

• Pregnancy, lactation

• Abnormal echocardiography before radiotherapy:

 - LVEF <50 %

 - Longitudinal strain > − 16 %

 - Longitudinal strain rate <1 %/s

 - Abnormal wall motion

• CCTA before radiotherapy showing that therapeutic management is required (by decision of the radiologist and cardiologist)

  1. 3D CRT 3D conformal radiation therapy, WHO World Health Organisation, CCTA coronary computed tomography angiography, LVEF left ventricular ejection fraction